title: Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight.
authors.forename: E C
authors.initials: EC
authors.lastname: Haley
authors.forename: C
authors.initials: C
authors.lastname: Lewandowski
authors.forename: B C
authors.initials: BC
authors.lastname: Tilley
mesh_terms: D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy*; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D002986:Clinical Trials as Topic; D006801:Humans; D009316:National Institutes of Health (U.S.); D010960:Plasminogen Activators / Q000009:adverse effects / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator